Sudipta Mazumder
Internal Medicine · Charlotte, NCNPI 1467560805
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations.
Across 159 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$291
- Novo Nordisk$266
- AstraZeneca$261
- AbbVie$233
- Merck$140
- Eisai Inc.$131
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,604100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 18 | $291 |
| Novo Nordisk | 17 | $266 |
| AstraZeneca | 17 | $261 |
| AbbVie | 15 | $233 |
| Merck | 9 | $140 |
| Eisai Inc. | 9 | $131 |
| Boehringer Ingelheim | 7 | $124 |
| Amgen | 7 | $122 |
| Biohaven Pharmaceuticals, Inc. | 9 | $115 |
| Vanda Pharmaceuticals Inc. | 4 | $112 |
| Abbott | 5 | $109 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $97 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $92 |
| Xeris Pharmaceuticals, Inc. | 4 | $82 |
| Bayer | 5 | $75 |
| Teva Pharmaceuticals USA, Inc. | 5 | $72 |
| Amarin Pharma, Inc. | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Pfizer | 2 | $31 |
| Biogen | 2 | $31 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Bausch Health US, LLC | 2 | $26 |
| Global Blood Therapeutics, Inc. | 1 | $18 |
| Edwards Lifesciences | 1 | $17 |
| Corcept Therapeutics | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Novartis | 1 | $14 |
How this compares
$2,604 in reported general payments places this provider in the 85th percentile of 3,302 internal medicine providers in North Carolina.
Other internal medicine in Charlotte
- Saad UsmaniCharlotte$551K
- Marc JohnsonCharlotte$342K
- Maithili ChitnavisCharlotte$267K
- Jonathan SchwartzCharlotte$193K
- Perry RoyCharlotte$135K
- Benjamin BrooksCharlotte$91K
- Mark SchwartzCharlotte$80K
- Thomas WalshCharlotte$64K
- Lisa BellanfonteCharlotte$45K
- Nirmish ShahDurham$862K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.